Home Search

tnty - search results

If you're not happy with the results, please do another search
Mitesco, Biotech Stock Review

Medtech Incubator True Nature | Mitesco (TNTY) Adds Another Heavy Hitter to Board.

True Nature Holding, Inc. DBA Mitesco, Inc. Adds Distinguished Healthcare Executive to Board of Directors.

Citius Pharma (CTXR), Fortress Biotech (FBIO) and True Nature (TNTY) Significantly Higher on News.

Fortress Bio (FBIO, $2.42) Up 43%, Citius Pharma (CTXR, $1.15) Up 109% and True Nature Holdings (TNTY, $0.043) Up 117%, Since Adding...

True Nature|Mitesco (TNTY). Coverage Report Issued.

Record Volume and Gradually Rising Price Portends to Higher Prices in 2020 as True Nature Executes on Recently Announced Incubator Strategy.
Mitesco, Biotech Stock Review

True Nature (TNTY), a Medtech Startup Incubator Pays Down Some Toxic Notes.

This is a Welcome Step in the Right Direction. ATLANTA, GA, Nov. 29, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE...
True Nature, Mitesco, Biotech Stock Review

Is True Nature (TNTY) $0.04, Nearing a Breakout?

After a Tough Year, a Series of Development Releases Appears to Have Halted True Natures Downtrend and Move to a Possible...
True Nature, Mitesco, Biotech Stock Review

True Nature’s (TNTY) CEO Larry Diamond on Wall Street Analyzer.

Larry Diamond Reveals Some of True Nature's Goals and Ambitions to Incubate Medical Related Startups to Benefit All Shareholders.
True Nature, Biotech Stock Review

True Nature | Mitesco (TNTY), Perking Up.

Is it too early to nick-name True Nature's Medtech incubator Mitesco the "Mighty Mitesco?" Of course it's too early - but it...
Biotech Stock Review

True Nature (TNTY) Mitesco Set to Launch Mitesco PLC Incubator — Aligns With Matheson...

Hires Legal Powerhouse Matheson as Counsel and Advisor on its European Acquisitions Efforts. Established...

True Nature (TNTY) Readies Launch of Mitesco: “The Medtech Incubator”

ATLANTA, GA, Nov. 05, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- True Nature Holding, Inc. (OTCQB: TNTY, “the Company”) today announced that...

Latest article

Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.

Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!

Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.

CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...

GeoVax (GOVX) Launches Vaccine Manufacturing System.

GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System Manufacturing Process for Phase 3 and Commercial Production...